How to Read a Peptide Certificate of Analysis

What is a peptide Certificate of Analysis?

A Certificate of Analysis, or COA, is an analytical laboratory report tied to a single manufacturing batch of a single product. It records what the material is, how pure it is, and which validated methods were used to establish both. In the analytical framework published for synthetic peptide therapeutics, identity, purity, and strength are each determined against a well-characterized reference standard, and those attributes are exactly what a COA is meant to document (source 1). A supplier's marketing claim asserts quality; a COA lets a researcher check it against measured data.

Because a COA describes one batch, it is only meaningful when its results can be traced back to the specific vial on the bench. That link is the lot number, and confirming it is the first step before reading any figure on the page.

What are the sections of a peptide COA?

Most peptide COAs are organized into a predictable set of sections. Reading one efficiently means knowing what each section is supposed to establish and what a weak or missing entry implies.

How is a peptide's identity confirmed on a COA?

Identity answers a single question: is the molecule in the vial the peptide it claims to be? The standard tool is mass spectrometry. Every peptide has a theoretical mass calculated from its amino-acid sequence, and the instrument reports an observed mass for the sample. When the observed mass matches the theoretical mass within the method's accuracy, the identity is consistent with the stated sequence. Both electrospray ionization (ESI) and matrix-assisted laser desorption/ionization (MALDI) are established techniques for determining the molecular weight of peptides and proteins, and the choice of method affects the accuracy and precision of that mass measurement (source 2).

A matching mass confirms the molecular weight, not the exact order of residues. To verify the sequence itself, laboratories use tandem mass spectrometry — in one published characterization program, electrospray LC–MS/MS was used to confirm both the mass and the amino-acid sequence of peptide reference standards (source 1). On a COA, identity therefore appears as a stated theoretical mass, an observed mass, and often the ionization method used to obtain it — a section covered in more depth in how mass spectrometry verifies a peptide's identity.

What does the purity percentage on a COA actually mean?

Purity is measured separately from identity, and it is where most COAs are read too quickly. The dominant method is reversed-phase high-performance liquid chromatography (RP-HPLC), which was used to determine homogeneity, identity, content, and purity for synthetic peptide reference standards in published work (source 1). RP-HPLC separates a sample into its components as they elute from the column, and each component registers as a peak.

The reported purity is a peak-area figure: the area of the target peptide peak divided by the total area of all peaks, expressed as a percentage. A value of 99.1 percent means the main peak accounts for 99.1 percent of the total detected area, while everything else — synthesis by-products, truncated or deletion sequences, and degradation products — makes up the remaining 0.9 percent. A purity number printed without naming its method, or with no chromatogram attached to support it, is a figure that cannot be checked.

Regulatory thresholds give a sense of scale. FDA guidance for certain highly purified synthetic peptide drug products states that any impurity present above 0.10 percent of the peptide should be individually identified, and a new specified impurity above 0.5 percent generally must be qualified before the product can proceed (source 3). Research-grade synthetic peptides are commonly specified at 95 percent or higher; Steadfast Research Group publishes the measured purity for each batch and documents the supporting HPLC and mass-spectrometry data batch by batch.

How do you read an HPLC chromatogram?

A chromatogram plots detector signal against time, and three features carry most of the information. Retention time is when a component leaves the column; the target peptide elutes at a characteristic time that should be consistent across a batch. Peak area is the quantity: the main peak's share of total area is the purity figure. The baseline and minor peaks reveal the rest — because purity is a normalized area calculation, every impurity that the method resolves shows up as its own separate peak (source 1).

Read visually, a single, sharp, symmetrical main peak sitting on a flat baseline is the signature of a well-resolved, high-purity sample. A cluster of smaller peaks, a shoulder riding on the main peak, or a drifting baseline points to impurities or to a method that is not cleanly separating them. A summary certificate with a purity number but no chromatogram removes the ability to see any of this, which is why an attached chromatogram is part of a complete COA.

What do the heavy-metal, endotoxin, and sterility sections show?

Beyond identity and purity, some COAs carry additional analytical sections depending on the material's grade and intended research application — peptide quality control is built on a battery of complementary tests rather than any single measurement (source 1). These may include residual counterion content (such as trifluoroacetate or acetate left from synthesis), water content, and, for certain applications, endotoxin measured by a Limulus amebocyte lysate (LAL) assay or a sterility result. Not every research peptide COA carries all of these; what matters is that the sections present match the grade the material is sold as, rather than reading any single line as automatically good or bad.

How does a lot number connect a vial to its COA?

A COA is batch-specific by design. The lot or batch number printed on the vial must match the lot number on the certificate; if they differ, the document does not describe the material in hand. Because a new batch is a new manufacturing run, a genuine testing program produces a new COA — with its own analytical data — for each lot. A certificate that is identical across every order, or that carries no lot number at all, is a generic marketing document rather than a batch analysis.

What are the red flags of a fake or weak COA?

• Only a summary number, with no chromatogram or mass spectrum attached.
• A purity value stated without naming the analytical method behind it.
• A lot number that does not match the vial, or no lot number anywhere on the document.
• The same certificate reused across different batches, or even different products.
• No testing-laboratory name, no analyst, and no date of analysis.
• Identity given as a compound name only, with no theoretical-versus-observed mass.

Why does batch-level, third-party testing matter?

Purity and identity are properties of a specific batch, not of a product name. Two lots of the same peptide can differ in their impurity profile, so a certificate that is not tied to the batch on hand verifies nothing about it. Independent third-party testing adds a second safeguard: a laboratory with no stake in the outcome reports the data. Reference-standard-based characterization of identity, purity, and content is the foundation of peptide quality control described in the published literature (source 1), and it only does its job when it is repeated for each batch. Every Steadfast Research Group product is independently tested and documented batch by batch, with a lot-matched COA available for each release — the same standard this article describes.